Mail

UK markets close in 1 hour 5 minutes

FTSE 100
8,196.08
-58.10(-0.70%)
FTSE 250
20,488.98
-216.29(-1.04%)
AIM
801.57
-6.79(-0.84%)
GBP/EUR
1.1753
+0.0005(+0.04%)
GBP/USD
1.2724
-0.0040(-0.32%)
Bitcoin GBP
53,226.39
-287.64(-0.54%)

Should you support your children at university or help them on to property ladder?

What parents should consider before making a financial decision

Sana Biotechnology, Inc. (SANA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

7.60

-0.20

(-2.56%)

As of 10:25AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	1.73B
Enterprise value	1.52B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	4.61
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-1.08

Trading information

Stock price history

Beta (5Y monthly)	1.62
52-week change ³	29.57%
S&P500 52-week change ³	26.94%
52-week high ³	12.00
52-week low ³	2.74
50-day moving average ³	8.83
200-day moving average ³	6.11

Share statistics

Avg vol (3-month) ³	1.77M
Avg vol (10-day) ³	1.34M
Shares outstanding ⁵	221.5M
Implied shares outstanding ⁶	221.5M
Float ⁸	129.01M
% held by insiders ¹	8.63%
% held by institutions ¹	89.95%
Shares short (15 May 2024) ⁴	25.48M
Short ratio (15 May 2024) ⁴	12.33
Short % of float (15 May 2024) ⁴	23.99%
Short % of shares outstanding (15 May 2024) ⁴	11.51%
Shares short (prior month 15 Apr 2024) ⁴	26.72M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-30.95%
Return on equity (ttm)	-76.82%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-329.69M
Net income avi to common (ttm)	-308.61M
Diluted EPS (ttm)	-1.48
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	311.08M
Total cash per share (mrq)	1.4
Total debt (mrq)	106.09M
Total debt/equity (mrq)	28.28%
Current ratio (mrq)	6.07
Book value per share (mrq)	1.70

Cash flow statement

Operating cash flow (ttm)	-239.94M
Levered free cash flow (ttm)	-234.63M